A detailed history of Capital International Investors transactions in Eli Lilly & CO stock. As of the latest transaction made, Capital International Investors holds 7,085,536 shares of LLY stock, worth $5.44 Billion. This represents 1.25% of its overall portfolio holdings.

Number of Shares
7,085,536
Previous 7,304,869 3.0%
Holding current value
$5.44 Billion
Previous $6.61 Billion 5.09%
% of portfolio
1.25%
Previous 1.39%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$772.14 - $960.02 $169 Million - $211 Million
-219,333 Reduced 3.0%
7,085,536 $6.28 Billion
Q2 2024

Aug 13, 2024

BUY
$724.87 - $909.04 $241 Million - $302 Million
332,476 Added 4.77%
7,304,869 $6.61 Billion
Q1 2024

May 14, 2024

BUY
$592.2 - $792.28 $199 Million - $266 Million
335,560 Added 5.06%
6,972,393 $5.42 Billion
Q4 2023

Feb 13, 2024

BUY
$525.19 - $619.13 $261 Million - $308 Million
497,079 Added 8.1%
6,636,833 $3.87 Billion
Q3 2023

Nov 13, 2023

SELL
$434.7 - $599.3 $25.7 Million - $35.4 Million
-59,018 Reduced 0.95%
6,139,754 $3.3 Billion
Q2 2023

Aug 11, 2023

SELL
$350.74 - $468.98 $119 Million - $159 Million
-339,139 Reduced 5.19%
6,198,772 $2.91 Billion
Q1 2023

May 15, 2023

BUY
$310.63 - $364.82 $239 Million - $281 Million
769,496 Added 13.34%
6,537,911 $2.25 Billion
Q4 2022

Feb 14, 2023

BUY
$321.55 - $374.67 $54.4 Million - $63.4 Million
169,241 Added 3.02%
5,768,415 $2.11 Billion
Q3 2022

Nov 14, 2022

BUY
$296.48 - $337.87 $189 Million - $215 Million
637,189 Added 12.84%
5,599,174 $1.81 Billion
Q2 2022

Aug 15, 2022

SELL
$278.73 - $327.27 $1.08 Billion - $1.27 Billion
-3,877,256 Reduced 43.86%
4,961,985 $1.61 Billion
Q1 2022

May 16, 2022

BUY
$234.69 - $291.66 $484 Million - $602 Million
2,063,557 Added 30.46%
8,839,241 $2.53 Billion
Q4 2021

Feb 14, 2022

SELL
$224.85 - $279.04 $78.8 Million - $97.8 Million
-350,561 Reduced 4.92%
6,775,684 $1.87 Billion
Q3 2021

Nov 15, 2021

SELL
$221.6 - $272.71 $308 Million - $379 Million
-1,390,834 Reduced 16.33%
7,126,245 $1.65 Billion
Q2 2021

Aug 16, 2021

SELL
$180.55 - $233.54 $67.6 Million - $87.4 Million
-374,281 Reduced 4.21%
8,517,079 $1.95 Billion
Q1 2021

May 14, 2021

SELL
$164.32 - $212.72 $407 Million - $527 Million
-2,476,761 Reduced 21.79%
8,891,360 $1.66 Billion
Q4 2020

Feb 12, 2021

SELL
$130.46 - $172.63 $622 Million - $823 Million
-4,768,570 Reduced 29.55%
11,368,121 $1.92 Billion
Q3 2020

Nov 13, 2020

SELL
$146.22 - $169.13 $738 Million - $853 Million
-5,044,616 Reduced 23.82%
16,136,691 $2.39 Billion
Q2 2020

Aug 14, 2020

SELL
$136.42 - $164.18 $218 Million - $262 Million
-1,595,488 Reduced 7.0%
21,181,307 $3.48 Billion
Q1 2020

May 15, 2020

SELL
$119.05 - $147.35 $390 Million - $483 Million
-3,279,138 Reduced 12.58%
22,776,795 $3.16 Billion
Q4 2019

Feb 18, 2020

BUY
$106.92 - $132.43 $97.4 Million - $121 Million
910,672 Added 3.62%
26,055,933 $3.42 Billion
Q3 2019

Nov 14, 2019

BUY
$106.79 - $116.16 $555 Million - $604 Million
5,197,510 Added 26.06%
25,145,261 $2.81 Billion
Q2 2019

Aug 14, 2019

BUY
$110.79 - $129.32 $430 Million - $502 Million
3,884,552 Added 24.18%
19,947,751 $2.21 Billion
Q1 2019

May 15, 2019

BUY
$111.31 - $131.02 $479 Million - $563 Million
4,300,569 Added 36.56%
16,063,199 $2.08 Billion
Q4 2018

Feb 14, 2019

BUY
$105.9 - $118.64 $162 Million - $181 Million
1,525,555 Added 14.9%
11,762,630 $1.36 Billion
Q3 2018

Nov 14, 2018

BUY
$85.86 - $107.31 $62 Million - $77.5 Million
722,431 Added 7.59%
10,237,075 $1.1 Billion
Q2 2018

Aug 14, 2018

BUY
$75.7 - $86.88 $36 Million - $41.3 Million
475,552 Added 5.26%
9,514,644 $812 Million
Q1 2018

May 15, 2018

BUY
$74.21 - $87.6 $296,765 - $350,312
3,999 Added 0.04%
9,039,092 $699 Million
Q4 2017

Feb 14, 2018

BUY
$81.94 - $87.89 $402 Million - $431 Million
4,907,902 Added 118.92%
9,035,093 $763 Million
Q3 2017

Nov 14, 2017

BUY
$77.07 - $85.54 $318 Million - $353 Million
4,127,191
4,127,191 $353 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $730B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Capital International Investors Portfolio

Follow Capital International Investors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital International Investors, based on Form 13F filings with the SEC.

News

Stay updated on Capital International Investors with notifications on news.